REVELATION BIOSCIENCES, INC.
Filed May 20, 2025.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed May 20, 2025
Contents
INTRODUCTORY NOTE
Effective January 28, 2025, we effected a 1-for-16 reverse stock split of our outstanding shares of common stock. Unless specifically provided otherwise herein, the share and per share information that follows in this prospectus, other than in the historical financial statements and related notes included elsewhere in this prospectus, assumes the effect of the reverse stock split.
On January 25, 2024, we effected the approved 1-for-30 reverse stock split of our outstanding shares of common stock.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.